<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03950635</url>
  </required_header>
  <id_info>
    <org_study_id>2018-0857</org_study_id>
    <secondary_id>NCI-2019-02496</secondary_id>
    <secondary_id>2018-0857</secondary_id>
    <secondary_id>P30CA016672</secondary_id>
    <nct_id>NCT03950635</nct_id>
  </id_info>
  <brief_title>Dietary Intervention in Patients With a History of Melanoma</brief_title>
  <official_title>Controlled Dietary Interventions in Patients With Melanoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research trial studies the effects of diet in patients with a history of melanoma. We&#xD;
      are studying the impact of 2 different diets; a whole-foods, fiber-rich diet and a ketogenic&#xD;
      diet. Participants will be assigned to one of these diets. During this study, participants&#xD;
      will be provided all food at no cost for the entire 6-week study. Food can be picked up or&#xD;
      shipped to the participant's home. However, participants will need to come into MD Anderson&#xD;
      Cancer Center in Houston, TX, for the initial screening visit and for blood tests every 2&#xD;
      weeks during the study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Background:&#xD;
&#xD;
      Whole-foods, fiber-rich diet rationale: Recent studies have shown that the gut microbiome&#xD;
      (the trillions of bacteria that live in our intestines) can influence our immune system&#xD;
      function. Diet plays a key role in shaping the gut microbiome. We will examine the effects of&#xD;
      a whole-food, fiber-rich diet on the gut microbiome within patients with a history of&#xD;
      melanoma.&#xD;
&#xD;
      Ketogenic diet rationale: The ketogenic diet is a very-low-carbohydrate, high-fat diet. The&#xD;
      goal of this diet is to change the body's fuel source from carbohydrates to fat and to lower&#xD;
      levels of insulin. We will examine the effects of a ketogenic diet to change metabolism&#xD;
      within patients with a history of melanoma.&#xD;
&#xD;
      Who can participate?&#xD;
&#xD;
      To be eligible for the study, participants must meet the following criteria:&#xD;
&#xD;
        -  Be at least 18 years old;&#xD;
&#xD;
        -  Meet the study requirements for Body Mass Index (BMI);&#xD;
&#xD;
        -  Have had melanoma within the last 5 years;&#xD;
&#xD;
        -  Be cancer-free at the start of the trial;&#xD;
&#xD;
        -  Have not received systemic therapy within the last year; and&#xD;
&#xD;
        -  Have no medical issues that would make them unable to follow these eating plans.&#xD;
&#xD;
      Study Design:&#xD;
&#xD;
      Our study will enroll up to 10 participants to each diet (high-fiber or ketogenic). After&#xD;
      screening, participants will have baseline assessment performed that will include collecting&#xD;
      diet information, blood and fecal samples, and body composition information. Participants&#xD;
      will then eat the provided diets for the next 6 weeks while coming in every 2 weeks for blood&#xD;
      and stool specimen collection. Six (6)weeks after the diet intervention is complete,&#xD;
      participants will come back to MD Anderson for one last end of study visit.&#xD;
&#xD;
      Who makes the meals?:&#xD;
&#xD;
      All calorie-containing food and beverages will be provided by either the MD Anderson Cancer&#xD;
      Center Bionutrition Research Core or Savor Health (a third-party vendor contracted by MD&#xD;
      Anderson).&#xD;
&#xD;
      Costs: There will be no cost to participate in this study.&#xD;
&#xD;
      Benefits:&#xD;
&#xD;
      All food and beverages you will eat as part of this study will be provided by the study and&#xD;
      can be shipped directly to your home. The results will be used to help us design future&#xD;
      dietary intervention trials in Melanoma patients receiving immunotherapy. Please note,&#xD;
      participants can withdraw from the study at any time without consequences.&#xD;
&#xD;
      Study PI: Dr. Jennifer McQuade&#xD;
&#xD;
      NCT#: NCT03950635&#xD;
&#xD;
      Contact Info:&#xD;
&#xD;
      Melanoma Medical Oncology (713)-792-5500 MelanomaDiet@mdanderson.org&#xD;
&#xD;
      Where: MD Anderson Cancer Center, Department of Melanoma Medical Oncology, Houston, TX&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2019</start_date>
  <completion_date type="Anticipated">November 29, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 29, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of conducting a controlled feeding study in melanoma patients</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Defined by &gt;= 25% of eligible patients enrolling on the protocol.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Melanoma</condition>
  <arm_group>
    <arm_group_label>Group I (fiber-rich diet)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients consume a whole-foods, fiber-rich diet for 6 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II (ketogenic diet)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients consume a high fat, low carbohydrate (ketogenic) diet for 6 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary Intervention</intervention_name>
    <description>Consume whole-foods, fiber-rich diet</description>
    <arm_group_label>Group I (fiber-rich diet)</arm_group_label>
    <other_name>Dietary Modification</other_name>
    <other_name>intervention, dietary</other_name>
    <other_name>Nutrition Intervention</other_name>
    <other_name>Nutrition Interventions</other_name>
    <other_name>Nutritional Interventions</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary Intervention</intervention_name>
    <description>Consume high fat, low carbohydrate (ketogenic) diet</description>
    <arm_group_label>Group II (ketogenic diet)</arm_group_label>
    <other_name>Dietary Modification</other_name>
    <other_name>intervention, dietary</other_name>
    <other_name>Nutrition Intervention</other_name>
    <other_name>Nutrition Interventions</other_name>
    <other_name>Nutritional Interventions</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Group I (fiber-rich diet)</arm_group_label>
    <arm_group_label>Group II (ketogenic diet)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Melanoma resected within the last 5 years, currently no evidence of disease (NED) and&#xD;
             not on systemic therapy.&#xD;
&#xD;
          -  Body mass index (BMI) 18.5-40 kg/m^2.&#xD;
&#xD;
          -  English-speaking.&#xD;
&#xD;
          -  Self-reported willingness to exclusively eat the provided diets.&#xD;
&#xD;
          -  Self-reported willingness to comply with scheduled visits, undergo venipuncture,&#xD;
             provide stool samples.&#xD;
&#xD;
          -  Creatinine (Cr) &lt; 1.5 mg/dL.&#xD;
&#xD;
          -  Liver function tests (LFTs) 2 x upper limit of normal (ULN).&#xD;
&#xD;
          -  Fasting glucose &lt; 125 mg/dL.&#xD;
&#xD;
          -  Women of child-bearing (WOCP) potential must have negative urine pregnancy test (UPT)&#xD;
             within 1 week prior to dual x-ray absorptiometry (DEXA) scan.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Systemic treatment for melanoma within the past 1 year.&#xD;
&#xD;
          -  Medical contraindications to the intervention diet as determined by the treating&#xD;
             physician.&#xD;
&#xD;
          -  Self-reported major dietary restrictions related to the intervention.&#xD;
&#xD;
          -  Diagnosis of diabetes mellitus type I or type II that requires medical treatment.&#xD;
&#xD;
          -  Unable or unwilling to undergo study procedures.&#xD;
&#xD;
          -  Antibiotic use within the last 30 days (self-reported and/or noted by the treating&#xD;
             physician).&#xD;
&#xD;
          -  Regularly taking probiotics, fiber supplements, or bile acid sequestrants, exogenous&#xD;
             ketones, weight loss supplements, appetite suppressants, carnitine supplements,&#xD;
             creatine supplements or diuretics within the last 30 days (self-reported and/or noted&#xD;
             by the treating physician).&#xD;
&#xD;
          -  Currently following a ketogenic diet with &gt; 70% calories derived from fat or consuming&#xD;
             &gt; 40 grams of fiber per day or a vegetarian or vegan diet.&#xD;
&#xD;
          -  Current self-reported smoker or heavy drinker (defined as &gt; 14 drinks per week) or&#xD;
             current self-reported illicit drug use.&#xD;
&#xD;
          -  Pregnant or lactating.&#xD;
&#xD;
          -  Low density lipoprotein (LDL) &gt; 200 mg/dL (within 28 days of screening).&#xD;
&#xD;
          -  Triglycerides &gt; 350 mg/dL (within 28 days of screening).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer McQuade</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer McQuade</last_name>
    <phone>713-792-2921</phone>
    <email>jmcquade@mdanderson.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer McQuade</last_name>
      <phone>713-792-2921</phone>
    </contact>
    <investigator>
      <last_name>Jennifer McQuade</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>MD Anderson Cancer Center Website</description>
  </link>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2018-0857.html</description>
  </link>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 6, 2019</study_first_submitted>
  <study_first_submitted_qc>May 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2019</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

